Correlation of subcellular and intratumoral photosensitizer localization with ultrastructural features after photodynamic therapy

Ultrastructural Pathology

Volumn 20, Issue 2, 1996, Pages 109-129

  Peng, Qian ^a,b   Moan, Johan ^a   Nesland, Jahn M ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b INSTITUTE OF CANCER RESEARCH   (Norway)

Author keywords

Confocal laser scanning microscopy; Distribution; Electron microscopy; Fluorescence microscopy; Histocytochemistry; Photodynamic; Photosensitizers; Singlet oxygen; Subcellular; Therapy; Tumor localization; Ultrastructural feature

Indexed keywords

ACRIDINE ORANGE; AMINOLEVULINIC ACID; BENZOPORPHYRIN DERIVATIVE; DYE; PHOTOFRIN; PHOTOSENSITIZING AGENT; PHTHALOCYANINE DERIVATIVE; PORPHYRIN DERIVATIVE; TALAPORFIN; TETRAKIS(3 HYDROXYPHENYL)CHLORIN; TETRAPHENYLPORPHYRIN; TETRAPHENYLPORPHYRIN DERIVATIVE;

CANCER; CANCER CELL CULTURE; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; LASER MICROSCOPY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; REVIEW; TISSUE DISTRIBUTION; ULTRASTRUCTURE;

EID: 0029960876     PISSN: 01913123     EISSN: None     Source Type: Journal    
DOI: 10.3109/01913129609016306     Document Type: Review

References (200)

1. Hayata Y, Kato H. Photodynamic therapy in treatment of early cancer. In: Henderson BW, Dougherty TJ, eds. Photodynamic Therapy: Basic Principle and Clinical Application. New York: Dekker; 1992:269-278.
2. Manyak MJ, Russo A, Smith PD, Glatstein E. Photodynamic therapy. J Oncol. 1988;6:380-391.
3. McCaughan JS Jr., Brown DG, Hawley PC, et al. Photodynamic therapy: an eight-year experience. In: Henderson BW, Dougherty TJ, eds. Photodynamic Therapy: Basic Principle and Clinical Application. New York: Dekker; 1992:323-331.
4. Pass HI, Delaney TF. Innovative photodynamic therapy at the National Cancer Institute: intraoperative intracavitary treatment. In: Henderson BW, Dougherty TJ, eds. Photodynamic Therapy: Basic Principle and Clinical Application. New York: Dekker; 1992:287-301.
5. Dougherty TJ, Marcus SL. Photodynamic therapy. Eur J Cancer. 1992;28A:1734-1742.
6. Dougherty TJ. Photodynamic therapy. Photochem Photobiol. 1993;58:895-900.
7. Moan J, Peng Q, Evensen JF, Berg K, Western A, Rimington C. Photosensitizing efficiencies, tumor-and cellular uptake of different photosensitizing drugs relevant for photodynamic therapy of cancer. Photochem Photobiol. 1987;46:713-721.
8. Weishaupt KR, Gomer CJ, Dougherty TJ. Identification of singlet oxygen as cytotoxic agent in photoinactivation of murine tumor. Cancer Res. 1976;36:2326-2329.
9. Ferraudi G, Arguello GA, Ali H, Van Lier JE. Types I and II sensitized photooxidation of aminoacid by phthalocyanines: a flash photochemical study. Photochem Photobiol. 1988;47:657-660.
10. Kimel S, Tromberg BJ, Roberts WG, Berns MW. Singlet oxygen generation of porphyrins, chlorins, and phthalocyanines. Photochem Photobiol. 1989;50:175-183.
11. Moan J. On the diffusion length of singlet oxygen in cells and tissues. J Photochem Photobiol. B:Biol. 1990;6:343-344.
12. Moan J, Berg K. The photodegradation of porphyrins in cells can be used to estimate the lifetime of singlet oxygen. Photochem Photobiol. 1991;53:549-553.
13. Peng Q, Moan J. Correlation of distribution of sulfonated aluminum phthalocyanines with their photodynamic effect in tumor and skin of mice bearing CaD2 mammary carcinoma. Br J Cancer. 1995;72:565-574.
14. Gomer CJ. Preclinical examination of first and second generation photosensitizers used in photodynamic therapy. Photochem Photobiol. 1991;54:1093-1107.
15. Moan J, Berg K. Photochemotherapy of cancer: experimental research. Photochem Photobiol. 1992;55:931-948.
16. Ben-Hur E, Rosenthal I. The phthalocyanines: a new class of mammalian cell photosensitizers with a potential for cancer phototherapy. Int J Radiat Biol. 1985;47:145-147.
17. Spikes JD. Phthalocyanines as photosensitizers in biological systems and for photodynamic therapy of tumors. Photochem Photobiol. 1986;43:691-700.
18. Rosenthal I. Phthalocyanines as photodynamic sensitizers. Photochem Photobiol. 1991;53:859-870.
19. Bonnett R, White RD, Winfield UJ, Berenbaum MC. Hydroporphyrins of the meso-tetra(hydroxyphenyl)porphyrin series as tumor photosensitizers. Biochem J. 1989; 261:277-280.
20. Bonnett R, Berenbaum MC. Porphyrins as photosensitizers. In: Bock G, Harnett S, eds. Photosensitizing Compounds: Their Chemistry, Biology and Clinical Use. Chichester, UK: Ciba Foundation Symposium 146, Wiley; 1989:40-59.
21. Spikes JD. New trends in photobiology: chlorins as photosensitizers in biology and medicine. J Photochem Photobiol B:Biol. 1990;6:259-274.
22. Richter AM, Kelly B, Chow J, et al. Preliminary studies on a more effective phototoxic agent than hematoporphyrin. J Natl Cancer Inst. 1987;79:1327-1332.
23. Richter AM, Waterfield E, Jain AK, Sternberg ED, Dolphin D, Levy JG. In vitro evaluation of phototoxic properties of four structurally related benzoporphyrin derivatives. Photochem Photobiol. 1990;52:495-500.
24. Villanueva A, Caggiari L, Jori G, Milanesi C. Morphological aspects of an experimental tumor photosensitized with a meso-substituted cationic porphyrin. J Photochem Photobiol B: Biol. 1994;23:49-56.
25. Shea CR, Sherwood ME, Flotte TJ, Chen N, Scholz M, Hasan T. Rhodamine 123 phototoxicity in laser-irradiated MGH-U1 human carcinoma cells studied in vitro by electron microscopy and confocal laser scanning microscopy. Cancer Res. 1990;50:4167-4172.
26. Morgan AR, Selman SH. New tetrapyrroles for photodynamic therapy. In: Kessel D, ed. Photodynamic Therapy of Neoplastic Diseases. Boca Raton, FL: CRC Press; 1990; 1:247-262.
27. Winkelman J. The distribution of tetraphenylporphine-sulfonate in the tumor-bearing rat. Cancer Res. 1962;22: 589-596.
28. 14C-labeled tetraphenylporphinesulfonate. Cancer Res. 1967;27:2060-2064.
29. Kessel D, Thompson P, Saatio K, Nantwi KD. Tumor localization and photosensitization by sulfonated derivatives of tetraphenylporphine. Photochem Photobiol. 1987;45:787-790.
30. Berg K, Bommer JC, Winkelman JW, Moan J. Cellular uptake and relative efficiency in cell inactivation by photoactivated sulfonated meso-tetraphenylporphines. Photochem Photobiol. 1990;52:775-781.
31. Berenbaum MC, Akande SL, Bonnett R, et al. meso-Tetra(hydroxyphenyl)porphyrins, a new class of potent tumor photosensitizers with favourable selectivity. Br J Cancer. 1986;54:717-725.
32. Jacobsen PB, Moan J. In vitro uptake and photodynamic action of tetra(3-hydroxyphenyl)porphyrin in cell. In: Moreno G, Pottier RH, Truscott TG, eds. Photosensitization. NATO ASI Series Berlin: Springer; 1988;H15:383-385.
33. Peng Q, Moan J, Nesland JM, Evensen JF, Kongshaug M, Rimington C. Localizing and photosensitizing mechanism by tetra(3-hydroxyphenyl)porphin in vivo on human malignant melanoma xenografts in athymic nude mice. Lasers Med Sci. 1990;5:399-409.
34. Malik Z, Djaldetti M. 5-Aminolevulinic acid stimulation of porphyrin and hemoglobin synthesis by uninduced friend erythroleukaemic cells. Cell Differ. 1979;8:223-233.
35. Malik Z, Lugaci H. Destruction of erythroleukaemic cells by photoactivation of endogenous porphyrins. Br J Cancer. 1987;56:589-595.
36. Bech Ø, Peng Q, Berg K, Moan J. Photosensitization of tumor cells in vitro and in vivo using endogenous porphyrins induced with exogenous 5-aminolevulinic acid. In: Spinelli P, Dal Fante M, Marchesini R, eds. Photodynamic Therapy and Biomedical Lasers. Amsterdam: Elsevier Science; 1992:521-525.
37. Bedwell J, MacRobert AJ, Phillips D, Bown SG. Fluorescence distribution and photodynamic effect of ALA-induced PPIX in the DMH rat colonic tumor model. Br J Cancer. 1992;65:818-824.
38. Berg K, Peng Q, Nesland JM, Moan J. Cellular response to photodynamic therapy. SPIE. 1993;2078:278-285.
39. Peng Q, Moan J, Warloe T, Nesland JM, Rimington C. Distribution and photosensitizing efficiency of porphyrins induced by application of exogenous 5-aminolevulinic acid in mice bearing mammary carcinoma. Int J Cancer. 1992;52:433-443.
40. Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX: basic principle and present clinical experience. J Photochem Photobiol B:Biol. 1990;6:143-148.
41. Kennedy JC, Pottier RH. Endogenous protoporphyrin IX, a clinical useful photosensitizer for photodynamic therapy. J Photochem Photobiol B:Biol. 1992;14:275-292.
42. Winkelman J. Intracellular localization of 'hematoporphyrin' in a transplanted tumor. J Natl Cancer Inst. 1961;27: 1369-1377.
43. Willingham MC, Pastan I. The visualization of fluorescent protein in living cells by video intensification microscopy (VIM). Cell. 1978;13:501-507.
44. Brakenhoff GJ, van der Voort HTM, van Spronsen EA, Linnemans WAM, Nanninga N. Three-dimensional chromatin distribution in neuroblastoma nuclei shown by confocal scanning laser microscopy. Nature. 1985;317: 748-749.
45. McConkey DJ, Orrenius S. Signal transduction pathways to apoptosis. Trends Cell Biol. 1994;4:370-374.
46. White JG, Amos WB, Fordham M. An evaluation of confocal versus conventional imaging of biological structures by fluorescence light microscopy. J Cell Biol. 1987; 105:41-48.
47. Peng Q, Moan J, Farrants G, Danielsen HE, Rimington C. Localization of potent photosensitizers in human tumor LOX by means of laser scanning microscopy. Cancer Lett. 1991;58:17-27.
48. Peng Q, Farrants GW, Madslien K, Bommer JC, Moan J, Danielsen HE, Nesland JM. Subcellular localization, redistribution and photobleaching of sulfonated aluminum phthalocyanines in a human melanoma cell line. Int J Cancer. 1991;49:290-295.
49. Woodburn KW, Vardaxis NJ, Hill JS, Kaye AH, Phillips DR. Subcellular localization of porphyrins using confocal laser scanning microscopy. Photochem Photobiol. 1991; 54:725-732.
50. Peng Q, Danielsen HE, Moan J. Application of confocal laser scanning microscopy for fluorescence detection of photosensitizing fluorophores in neoplastic cells and tissues. SPIE. 1993;2083:71-82.
51. Moan J, Johannessen JV, Christensen T, Espevik T, Mcghie JB. Porphyrin-sensitized photoinactivation of human cells in vitro. Am J Pathol. 1982;109:184-192.
52. Berns MW, Dahlman A, Johnson F, et al. In vitro cellular effects of hematoporphyrin derivative. Cancer Res. 1982; 42:2325-2329.
53. Coppola A, Viggiani E, Salzarulo L, Rasile G. Ultrastructural changes in lymphoma cells treated with hematoporphyrin and light. Am J Pathol. 1980;99:175-192.
54. Peng Q, Evensen JF, Rimington C, Moan J. A comparison of different photosensitizing dyes with respect to uptake by C3H-tumors and tissues of mice. Cancer Lett. 1987;36:1-10.
55. Malik Z, Babushkina T, Shafran M, Nordenberg Y, Mamet R. Schoenfeld N. Induction of protoporphyrin biosynthesis and photodynamic inactivation of B16 melanoma cells. SPIE. 1993;2078:355-362.
56. Chan WS, Svensen R, Phillips D, Hart IR. Cell uptake, distribution and response to aluminum sulphonated phthalocyanine, a potential anti-tumor photosensitizer. Br J Cancer. 1986;53:255-263.
57. Raquette B, Ali H, Langlois R, van Lier J. Biological activities of phthalocyanines, VIII: cellular distribution in V-79 Chinese hamster cells and phototoxicity of selectively sulfonated aluminum phthalocyanines. Photochem Photobiol. 1988;47:215-220.
58. Moan J, Berg K, Kvam E, et al. Intracellular localization of photosensitizers. In: Bock G, Harnett S, eds. Photosensitizing Compounds: Their Chemistry, Biology and Clinical Use. Chichester, UK: Ciba Foundation Symposium 146, Wiley; 1989:95-111.
59. Ben-Hur E, Green M, Prager A, Kol R, Rosenthal I. Phthalocyanine photosensitization of mammalian cells: biochemical and ultrastructural effects. Photochem Photobiol. 1987;46:651-656.
60. Berg K, Moan J. Mitotic inhibition by phenylporphines and tetrasulfonated aluminum phthalocyanine in combination with light. Photochem Photobiol. 1992;56:333-339.
61. Dubbelman TMAR, de Bruijne AW, van Seveninck J. Photodynamic effects of protoporphyrin on red blood cell deformability. Biochem Biophys Res Commun. 1977;77: 811-817.
62. Oseroff AR, Ohuoha D, Ara G, McAuliffe D, Foley J, Cincotta L. Intramitochondrial dyes allow selective in vitro photolysis of carcinoma cells. Proc Natl Acad Sci. 1986; 85:9729-9733.
63. Bachowski GJ, Pintar TJ, Girotti AW. Photosensitized lipid peroxidation and enzyme inactivation by membrane-bound merocyanine 540: reaction mechanisms in the absence of ascorbate. Photochem Photobiol. 1991;53: 481-491.
64. Valenzeno DP. Photomodification of biological membranes with emphasis on singlet oxygen mechanism. Photochem Photobiol. 1987;46:147-160.
65. Moan J, Christensen T. Photodynamic effects on human cells exposed to light in the presence of hematoporphyrin: localization of the active dye. Cancer Lett. 1981;11: 209-214.
66. Berg K, Bommer JC, Moan J. Evaluation of sulfonated aluminum phthalocyanines for use in photochemotherapy: a study on the relative efficiencies of photoinactivation. Photochem Photobiol. 1989;49:587-594.
67. Spikes JD, Bommer JC. Zinc tetrasulphophthalocyanine as a photodynamic sensitizer for biomolecules. Int J Radiat Biol. 1986;50:41-45.
68. Robinson RS, Robert AJ, Campbell ID. Photooxidation effects on β-hydroxybutyrate dehydrogenase: studies of membrane fragments and intact mitochondria. Photochem Photobiol. 1987;45:231-234.
69. Langlois R, Ali H, Brasseur N, Wagner JR, van Lier JE. Biological activities of phthalocyanines-IV: type II sensitized photooxidation of L-tryptophan and cholesterol by sulfonated phthalocyanines. Photochem Photobiol. 1986; 44:117-123.
70. Deuticke B, Henseleit U, Haest CWM, Heller KB, Dubbelman TMAR. Enhancement of transbilayer mobility of a membrane lipid probe accompanies formation of membrane leaks during photodynamic treatment of erythrocytes. Biochim Biophys Acta. 1989;982:53-61.
71. Bachowski GJ, Ben-Hur E, Girotti AW. Phthalocyanine-sensitized lipid peroxidation in cell membranes: use of cholesterol as a probe of primary photochemistry. Photochem Photobiol. 1990;51:64S.
72. Girotti AW. Photodynamic lipid peroxidation in biological systems. Photochem Photobiol. 1990;51:497-509.
73. Ben-Hur E, Fujihara T, Suzuki F, Elkind MM. Genetic toxicology of the photosensitization of Chinese hamster cells by phthalocyanines. Photochem Photobiol. 1987;45:227-230.
74. Ramakrishnan N, Clay ME, Xue LY, Evans HH, Rodriguez-Antunez A, Oleinick NL. Induction of DNA-protein cross-links in Chinese hamster cells by the photodynamic action of chloroaluminum phthalocyanine and visible light. Photochem Photobiol. 1988;48:297-303.
75. Kvam E, Moan J. A comparison of three photosensitizers with respect to efficiency of cell inactivation, fluorescence quantum yield and DNA strand breaks. Photochem Photobiol. 1990;52:769-773.
76. Moan J, Kvam E, Hovig E, Berg K. Effects of PDT on DNA and chromosomes. In: Riklis E, ed. Photobiology. New York: Plenum; 1991:821-829.
77. Agarwal ML, Clay ME, Harvey EJ, Evans HH, Antunez AR, Oleinick NL. Photodynamic therapy induces rapid cell death by apoptosis in L5178Y mouse lymphoma cells. Cancer Res. 1991;51:5993-5996.
78. Agarwal ML, Larkin HE, Zaidi SIA, Mukhtar H, Oleinick NL. Phospholipase activation triggers apoptosis in photosensitized mouse lymphoma cells. Cancer Res. 1993;53: 5897-5902.
79. Henderson BW, Dougherty TJ. How does photodynamic therapy work? Photochem Photobiol. 1992;55:145-157.
80. Kongshaug M, Minireview: distribution of tetrapyrrole photosensitizers among human plasma proteins. Int J Biochem. 1992;24:1239-1265.
81. Kessel D, Woodburn K, Biodistribution of photosensitizing agents. Int J Biochem. 1993;25:1377-1383.
82. Berg K, Bommer JC, Moan J. Evaluation of sulfonated aluminum phthalocyanines for use in photochemotherapy: cell uptake studies. Cancer Lett. 1989;44:7-15.
83. Allison BA, Pritchard PH, Richter AM, Levy JG. The plasma distribution of benzoporphyrin derivative and the effect of plasma lipoproteins on its biodistribution. Photochem Photobiol. 1990;52:501-507.
84. Ginevra F, Biffanti S, Pagnan A, Biolo R, Reddi E, Jori G. Delivery of the tumor photosensitizer Zn(II)-phthalocyanine to serum proteins by different liposomes: studies in vitro and in vivo. Cancer Lett. 1990;49:59-65.
85. Jori G, Reddi E. Strategies for tumor targeting by photodynamic sensitizers. In: Kessel D, ed. Photodynamic Therapy of Neoplastic Disease. Boca Raton, FL: CRC Press; 1990;2:117-130.
86. Jori G, Reddi E. The role of lipoproteins in the delivery of tumor-targeting photosensitizers. Int J Biochem. 1993;25: 1369-1375.
87. Kongshaug M, Rimington C, Evensen JF, Peng Q, Moan J. Hematoporphyrin diethers-V: plasma protein binding and photosensitizing efficiency. Int J Biochem. 1990;22: 1127-1131.
88. Reddi E, Zhou C, Biolo R, Menegaldo E, Jori G. Liposome- or LDL-administered Zn(II)-phthalocyanine as a photodynamic agent for tumors, 1: pharmacokinetic properties and phototherapeutic efficiency. Br J Cancer. 1990;61:407-411.
89. Barel A, Jori G, Perin A, Romandini P, Pagnan A, Biffanti S. Role of high-, low- and very-low-density lipoproteins in the transport and tumor-delivery of hematoporphyrin in vivo. Cancer Lett. 1986;32:145-150.
90. Reddi E, Castro LO, Biolo R, Jori G. Pharmacokinetic studies with zinc(II)-phthalocyanines in tumor-bearing mice. Br J Cancer. 1987;56:597-600.
91. Mazière JC, Morliere P, Santus R. The role of the low density lipoprotein receptor pathway in the delivery of lipophilic photosensitizers in the photodynamic therapy of tumors. J Photochem Photobiol B:Biol. 1991;8:351-360.
92. Lombardi P, Norata G, Maggi FM, et al. Assimilation of LDL by experimental tumors in mice. Biochim Biophys Acta. 1989;1003:301-306.
93. Vitols S, Söderberg-Reid K, Masquelier M, Bjostrom B, Peterson C. Low density lipoprotein for delivery of a water-insoluble alkylating agent to malignant cells: in vitro and in vivo studies of a drug-lipoprotein complex. Br J Cancer. 1990;62:724-729.
94. Zhou C, Milanesi C, Jori G. An ultrastructural comparative evaluation of tumors photosensitized by porphyrins administered in aqueous solution, bound to liposomes or to lipoproteins. Photochem Photobiol. 1988;48:487-492.
95. Jain RK. Transport of molecules in the tumor interstitium: a review. Cancer Res. 1987;47:3039-3051.
96. Jain RK. Transport of molecules across tumor vasculature. Cancer Metastasis Rev. 1987;6:559-594.
97. Peavy GM, Krasieva TB, Tromberg BJ. Eusantos ED, Berns MW. Variation in the distribution of a phthalocyanine photosensitizer in naturally occurring tumors of animals. Photochem Photobiol B:Biol. 1995:271-275.
98. Dvorak HF, Nagy JA, Dvorak JT, Dvorak AM. Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules. Am J Pathol. 1988;133:95-109.
99. Dvorak HF. Tumors: wounds that do not heal, similarities between tumor stroma generation and wound healing. New Engl J Med. 1986;31:1650-1659.
100. Peng Q, Nesland JM, Moan J, Evensen JF, Kongshaug M, Rimington C. Localization of fluorescent Photofrin II and aluminum phthalocyanine tetrasulfonate in transplanted human malignant tumor LOX and normal tissues of nude mice using highly light-sensitive video intensification microscopy. Int J Cancer. 1990;45:972-979.
101. Peng Q, Moan J, Nesland JM, Rimington C. Aluminum phthalocyanines with asymmetrical lower sulfonation and with symmetrical higher sulfonation: a comparison of localizing and photosensitizing mechanism in human tumor LOX xenografts. Int J Cancer. 1990;46:719-726.
102. Dougherty T. Photosensitization therapy and detection of malignant tumors. Photochem Photobiol. 1987;45:879-890.
103. Zhou C. Mechanisms of tumor necrosis induced by photodynamic therapy. J Photochem Photobiol B:Biol. 1989; 3:299-318.
104. Henderson BW, Farrell G. Possible implications of vascular damage for tumor cell inactivation in vivo: comparison of different photosensitizer. In: Dougherty TJ, ed. Photodynamic Therapy: Mechanisms. Washington, DC: SPIE; 1989;1065:2-10.
105. Milanesi C, Zhou C, Biolo R, Jori G. Zn(II)-phthalocyanine as a photodynamic agent for tumors, II: studies on the mechanism of photosensitized tumor necrosis. Br J Cancer. 1990;61:846-850.
106. Berenbaum MC, Hall GW, Hoyes AD. Cerebral photosensitization by hematoporphyrin derivative: evidence for an endothelial site of action. Br J Cancer. 1986;53:81-89.
107. Chandhuri K, Keck RW, Selman S. Morphological changes of tumor microvasculature following hematoporphyrin derivative sensitizer photodynamic therapy. Photochem Photobiol. 1987;46:823-827.
108. Henderson BW, Waldow SM, Mang TS, Potter WR, Malone PB, Dougherty TJ. Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapy. Cancer Res. 1985;45:572-576.
109. Henderson BW, Fingar VH. Relationship of tumor hypoxia and response to photodynamic treatment in an experimental mouse tumor. Cancer Res. 1987;47:3110-3114.
110. Henderson BW, Fingar VH. Oxygen limitation of direct tumor cell kill during photodynamic treatment of a murine tumor model. Photochem Photobiol. 1989;49:299-304.
111. Nelson JS, Liaw LH, Berns MW. Tumor destruction in photodynamic therapy. Photochem Photobiol. 1987;46: 829-835.
112. Nelson JS, Liaw LH, Orenstein A, Roberts WG, Berns MW. Mechanism of tumor destruction following photodynamic therapy with hematoporphyrin derivative, chlorin and phthalocyanine. J Natl Cancer Inst. 1988;80: 1599-1605.
113. Selman SH, Kreimer-Birnbaum M, Klauning JE, Goldblatt PJ, Keck RW, Britton S. Blood flow in transplanted bladder tumors treated with hematoporphyrin derivative and light. Cancer Res. 1984;44:1924-1927.
114. Star WM, Marijnissen HPA, van den Berg-Blok AE, Versteeg JAC, Franken KAP, Reinhold HS. Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in vivo in sandwich observation chambers. Cancer Res. 1986;46:2532-2540.
115. Tromberg BJ, Orenstein A, Kimel S, et al. In vivo tumor oxygen tension measurements for the evaluation of the efficiency of photodynamic therapy. Photochem Photobiol. 1990;52:375-385.
116. Fingar FH, Wieman TJ, Wiehle SA, Cerrito PB. The role of microvascular damage in photodynamic therapy; the effect of treatment on vessel constriction, permeability, and leukocyte adhesion. Cancer Res. 1992;52:4914-4921.
117. Franken NAP, Vrensen GJFM, van Delft JL, et al. Early morphological changes induced by photodynamic therapy in amelanotic Greene melanoma implanted in the anterior eye chamber of rabbits. Lasers Med Sci. 1988;3: 27-34.
118. Selman SH, Keck RW, Klauning JE, Kreimer-Birnbaum M, Goldblatt PJ, Britton SL. Acute blood flow changes in transplantable FANFT-induced urothelial tumors treated with hematoporphyrin derivative and light. Surg Forum. 1983;34:676-678.
119. Ben-Hur E. Mechanisms of blood flow stoppage by photodynamic therapy. Spectrum. 1990;3:3-4.
120. Ben-Hur E, Orenstein A. The endothelium and red blood cells as potential targets in PDT-induced vascular stasis. Int J Radiat Biol. 1991;60:293-301.
121. Ben-Hur E, Dubbelman TMAR, van Stevenick J. Phthalocyanine-induced photodynamic changes of cytoplasmic free calcium in Chinese hamster cells. Photochem Photobiol. 1991;54:163-166.
122. Yonuschot G. Early increase in intracellular calcium during photodynamic permeabilization. Free Read Biol Med. 1991;11:307-317.
123. Foster TH, Primavera MC, Marder VJ, Hilf R, Sporn LA. Photosensitized release of von Willebrand Factor from cultured human endothelial cells. Cancer Res. 1991;51: 3261-3266.
124. Peng Q, Moan J, Nesland JM. An ultrastructural evaluation of CaD2 mouse mammary carcinoma after photodynamic therapy with meso-tetra(hydroxyphenyl)porphyrin (m-THPP) or its corresponding chlorin (m-THPC). SPIE. 1994;2329:281-290.
125. Ris HB, Altermatt HJ, Indebitzi R, et al. Photodynamic therapy with chlorins for diffuse malignant mesothelioma: initial clinical results. Br J Cancer. 1991;64:1116-1120.
126. Reed MWR, Wieman TJ, Doak KW, Pietsch K, Schuschke DA. The microvascular effects of photodynamic therapy: evidence for a possible role of cyclooxygenase products. Photochem Photobiol. 1989;50:419-423.
127. Kerdel FA, Soter NA, Lim HW. In vivo mediator release and degranulation of mast cells in hematoporphyrin derivative-induced phototoxicity in mice. J Invest Dermatol. 1987;88:277-280.
128. He D, Soter NA, Lim HW. The later phase of hematoporphyrin derivative-induced phototoxicity in mice: release of histamine and histologic changes. Photochem Photobiol. 1989;50:91-95.
129. Choop M. Glasberg MR, Riddle JM, Hetzel FM, Welch KMA. Photodynamic therapy of normal cerebral tissue in the cat: a noninvasive model for cerebrovascular thrombosis. Photochem Photobiol. 1987;46:103-108.
130. Henderson BW, Dougherty TJ, Malone PB. Studies on the mechanism of tumor destruction by photoradiation therapy. In: Doiron DR, Gomer CJ, eds. Porphyrin Localization and Treatment of Tumors. New York: Liss; 1984: 601-612.
131. Klauning JE, Selman SH, Shulok JR, Schsfer PJ, Britton SL, Goldblatt PJ. Morphological studies on bladder tumors treated with hematoporphyrin derivative photochemotherapy. Am J Pathol. 1985;119:236-243.
132. Gomer CJ, Rucker N, Ferrario A, Murphree AL. Cellular and molecular evaluation of photodynamic therapy. Lasers Med Sci. 1988(July); Abstracts Issue:99.
133. Bugelski P, Porter C, Dougherty T. Autoradiographic distribution hematoporphyrin derivative in normal and tumor tissue of the mouse. Cancer Res. 1981;41:4606-4612.
134. Carpenter RJ, Ryan RJ, Neel HB, Sanderson DR. Tumor fluorescence with hematoporphyrin derivative. Ann Otol. 1977;86:661-666.
135. Musser DA, Wagner JM, Datta-Gupta N. The interac tion of tumor localizing porphyrins with collagen and elastin. Res Commun Chem Pathol Pharmacol. 1982;2: 251-259.
136. Korbelik M, Krosl G, Chaplin DJ. Photofrin uptake by murine macrophages. Cancer Res. 1991;51:2251-2255.
137. Korbelik M, Krosl G, Olive PL, Chaplin DJ. Distribution of Photofrin between tumors and tumor associated macrophages. Br J Cancer. 1991;64:508-512.
138. Korbelik M. Distribution of disulfonated and tetrasulfonated aluminum phthalocyanine between malignant and host cell populations of a murine fibrosarcoma. J Photochem Photobiol B:Biol. 1993;20:173-181.
139. Evans S, Matthews W, Perry R, Frankel D, Norton J, Pass HI. Effects of photodynamic therapy on tumor necrosis factor production by murine macrophages. J Natl Cancer Inst. 1990;82:34-39.
140. Bellnier DA. Potentiation of photodynamic therapy in mice with recombinant human tumor necrosis factors-α. J Photochem Photobiol B:Biol. 1991;8:203-210.
141. Schumaker BP, Hetzel FW. Clinical laser photodynamic therapy in the treatment of bladder carcinoma. Photochem Photobiol. 1987;46:899-901.
142. Yamamoto K, Kawanishi S. Oxidation of specific SH groups of mitochondria by photodynamic action of hematoporphyrin: relevance to uncoupling of oxidative phosphorylation. Biochem Pharmacol. 1991;42:1087-1092.
143. Marshall JF, Chan WS, Hart IR. Effect of photodynamic therapy on anti-tumor immune defenses: comparison of the photosensitizers hematoporphyrin derivative and chloro-aluminum sulfonated phthalocyanine. Photochem Photobiol. 1989;49:627-632.
144. Jolles C, Ott MJ, Straight RC, Lynch DH. Systemic immunosuppression induced by peritoneal photodynamic therapy. Am J Obstet Gynecol. 1988;158:1446-1453.
145. Musser DA, Fiel RJ. Cutaneous photosensitizing and immunosuppressive effects of a series of tumor localizing porphyrins. Photochem Photobiol. 1991;53:119-123.
146. Winkelman J, Rasmussen-Taxdal DS. Quantitative determination of porphyrin uptake by tumor tissue following parenteral administration. Bull Johns Hopkins Hosp. 1960;107:228-233.
147. Rasmussen-Taxdal DS, Ward GE, Figge FH. Fluorescence of human lymphatic and cancer tissues following high doses of intravenous hematoporphyrin. Cancer. 1955;8: 78-81.
148. Lipson RL, Baldes EJ, Olsen AM. The use of a derivative of haematoporphyrin in tumor detection. J Natl Cancer Inst. 1961;26:1-11.
149. Lipson RL, Baldes EJ, Olsen AM. Hematoporphyrin derivative: a new aid for endoscopic detection of malignant diseases. J Thorac Cardiovasc Surg. 1961;42:623-629.
150. Lipson RL, Baldes EJ, Olsen AM. Hematoporphyrin derivative for detection and management of cancer. Proc IX Int Cancer Congr. 1966:393.
151. Gregorie HG, Horger EO, Ward JL, et al. Hematoporphyrin derivative fluorescence in malignant neoplasms. Ann Surg. 1968;167:820-828.
152. Dougherty TJ, Grindey GB, Fiel KR, Weishaupt KR, Boyle DG. Photoradiation therapy, II: cure of animal tumors with hematoporphyrin and light. J Natl Cancer Inst. 1975; 55:115-121.
153. Tsutsui M, Carrano C, Sutsui EA. Tumor localizers: porphyrins and related compounds (unusual metalloporphyrins XIII). Ann NY Acad Sci. 1975;244:674-684.
154. Atlante A, Moreno G, Passarella S, Salet C. Hematoporphyrin derivative (Photofrin II) photosensitization of isolated mitochondria: impairment of anion translocation. Biochem Biophys Res Commun. 1986;141:584-590.
155. Dubbelman TMAR, van Steveninck J. Photodynamic effect of hematoporphyrin derivative on transmembrane transport system of murine L929 fibroblasts. Biochim Biophys Acta. 1984;771:201-207.
156. Hilf R, Smail DB, Murant RS, Leake PB, Gibson SL. Hematoporphyrin derivative-induced photosensitivity of mitochondrial succinate dehydrogenase and selected cytosolic enzymes of R3230 AC mammary adenocarcinomas of rats. Cancer Res. 1984;44:1483-1488.
157. Gibson SL, Hilf R. Photosensitization of mitochondrial cytochrome c oxidase by hematoporphyrin derivative and related porphyrins in vitro and in vivo. Cancer Res. 1983;43:4191-4197.
158. Perlin DS, Murant RS, Gibson SL, Hilf R. Effects of photosensitization by hematoporphyrin derivative on mitochondrial triphosphate-mediated proton transport and membrane integrity of R3230 AC mammary adenocarcinoma. Cancer Res. 1985;45:653-658.
159. 31P-NMR spectroscopy demonstrates decreased ATP levels in vivo as an early response to photodynamic therapy. Biochem Biophys Res Commun. 1986;140:273-279.
160. Hilf R, Gibson SL, Penney DP, Ceckler TL, Bryant RG. Early biochemical response to photodynamic therapy monitored by NMR spectroscopy. Photochem Photobiol. 1987;46:809-817.
161. Fingar VH, Wieman TJ, Karavolos PS. The effects of photodynamic therapy using differently substituted zinc phthalocyanines on vessel constriction, vessel leakage and tumor response. Photochem Photobiol. 1993;58:251-258.
162. Hampton JA, Selman SH. Mechanisms of cell killing in photodynamic therapy using a novel in vivo drug/in vitro light culture system. Photochem Photobiol. 1992;56:235-243.
163. Peng Q, Moan J, Kongshaug M, Evensen JF, Anholt H, Rimington C. Sensitizer for photodynamic therapy of cancer: a comparison of the tissue distribution of Photofrin II and aluminum phthalocyanine tetrasulfonate in nude mice bearing a human malignant tumor. Int J Cancer. 1991;48:258-264.
164. 2) in mice bearing a human malignant tumor. Lasers Life Sci. 1993;5:175-184.
165. Peng Q, Moan J, Cheng LS. The effect of glucose administration on the uptake of Photofrin II in a human tumor xenograft. Cancer Lett. 1991;58:29-35.
166. 4 in human tumor LOX in vitro and in vivo by means of computer-enhanced video fluorescence microscopy. Cancer Lett. 1991;58:37-47.
167. Peng Q, Brown SB, Moan J, et al. Biodistribution of a methylene blue derivative in tumor and normal tissue of rats. J. Photochem Photobiol B:Biol. 1993;20:63-71.
168. Peng Q, Ma LW, Berg K, Moan J. Effect of sulfonation on the photosensitizing efficiency of aluminum phthalocyanine and meso-tetraphenylporphine in photodynamic therapy of cancer. SPIE. 1993;2078:258-267.
169. Peng Q, Nesland JM, Madslien K, Danielsen HE, Moan J. Subcellular photodynamic action sites of sulfonated aluminum phthalocyanines in a human melanoma cell line. SPIE. 1996;2628:in press.
170. Peng Q. Unpublished data. 1985.
171. Detty MR, Merkel PB, Hilf R, Gibson SL, Powers SK. Chalcogenapyrylium dyes as photochemotherapeutic agents: tumor uptake, mitochondrial targeting and singlet-oxygen-induced inhibition of cytochrome c oxidase. J Med Chem. 1990;33:1108-1116.
172. Malik Z, Chitayat SD, Langzam Y. Hemin dependent morphological maturation and endogenous porphyrin synthesis by K562 leukemic cells. Cancer Lett. 1988;41:203-209.
173. Shulok JR, Klaunig JE, Selman SH, Schafer PJ, Goldblatt PJ. Cellular effects of hematoporphyrin derivative photodynamic therapy on normal and neoplastic rat bladder cells. Am J Pathol. 1986;122:277-283.
174. Davies CdeL, Ranheim T, Malik Z, Rofstad EK, Moan J, Lindmo T.
175. Evensen JF, Malik Z, Moan J. Ultrastructural changes in the nuclei of human carcinoma cells after photodynamic treatment with hematoporphyrin derivative and tetrasodium-meso-tetra(4-sulphonatophenyl)porphine. Lasers Med Sci. 1988;3:195-206.
176. Deng YH, Liang H. Scanning electron microscopic observation on photodynamic effects in cells in vitro. Lasers Med Sci. 1990;5:375-379.
177. Yu DS, Chang SY, Ma CP. Ultrastructural changes of bladder cancer cells following methylene blue-sensitized photodynamic treatment. Eur Urol. 1991;19:322-326.
178. Roberts WG, Liaw LH, Berns MW. An electron microscopy study of cellular destruction with mono-L-aspartyl chlorin e6 and photofrin II. Lasers Surg Med. 1989;9:102-108.
179. He XY, Sikes RA, Thomsen S, Chung LWK, Jacques SL. Photodynamic therapy with photofrin II induces programmed cell death in carcinoma cell lines. Photochem Photobiol. 1994;59:468-473.
180. Miller K, Reich E, Ruck A, Hautmann R. Photodynamic therapy of bladder cancer: uptake and phototoxicity of photosan in vitro. Urol Res. 1991;19:353-356.
181. Zaidi SIA, Oleinick NL, Tarif-Zaim M, Mukhtar H. Apoptosis during photodynamic therapy-induced ablation of RIF-1 tumors in C3H mice: electron microscopic, histopathologic and biochemical evidence. Photochem Photobiol. 1993;58:771-776.
182. Tatsuta M, Iishi H, Yamamura H, Yamamoto R, Okuda S. Comparison of photodynamic inactivation of experimental stomach tumors sensitized by acridine orange or hematoporphyrin derivatives. Oncology. 1988;45: 35-40.
183. Schuitmaker JJ, Vrensen GF, van Delft JL, de Wolff-Rouendaal D, Dubbelman TM, de Wolf A. Morphologic effects of bacteriochlorin a and light in vivo on intraocular melanoma. Invest Ophthalmol Vis Sci. 1991;32:2683-2688.
184. Milanesi C, Biolo R, Jori G, Schaffner K. Experimental photodynamic therapy with tetrapropyl-porphycene: ultrastructural studies on the mechanism of tumor photodamage. Lasers Med Sci. 1991;6:437-442.
185. Kato H, Aizawa K, Shinohara H, et al. Cytomorphological changes caused by hematoporphyrin derivative and photodynamic therapy. Lasers Life Sci. 1986;1:13-27.
186. Zhou CN, Xu BZ, Xie JG, et al. An ultrastructural study of human bladder cancer treated by photodynamic therapy. Lasers Med Sci. 1988;3:87-92.
187. Winther J, Ehlers N. Histopathological changes in an intraocular retinoblastoma-like tumor following photodynamic therapy. Acta Ophthalmol Copenh. 1988;66: 69-78.
188. Milanesi C, Biolo R, Reddi E, Jori G. Ultrastructural studies on the mechanism of the photodynamic therapy of tumors. Photochem Photobiol. 1987;46:675-681.
189. Warloe T, Peng Q, Heyerdahl H, Moan J, Steen HB, Giercksky K-E. Photodynamic therapy with 5-aminolevulinic acid induced porphyrins and DMSO EDTA for basal cell carcinoma. In 5th International Photodynamic Association Biennial Meeting, Denis A. Cortese, Editor. Proc. SPIE. 1995;2371:226-235.
190. Wolf P, Rieger E, Kerl H. Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. J Am Acad Dermatol. 1993;28:17-21.
191. Svanberg K, Andersson T, Killander D, et al. Photodynamic therapy of non-melanoma malignant tumors of the skin using topical 5-amino-levulinic acid sensitization and laser irradiation. Br J Dermatol. 1994;130:743-751.
192. Loh CS, Bedwell J, MacRobert AJ, Krasner N, Phillips D, Bown SG. Photodynamic therapy of the normal rat stomach: a comparative study between disulphonated aluminum phthalocyanine and 5-aminolevulinic acid. Br J Cancer. 1992;66:452-462.
193. Loh CS, MacRobert AJ, Regula J, Bown SG. Oral vs i.v. administration of 5-ALA. Br J Cancer. 1993;68:41-51.
194. Grant WE, Hopper C, MacRobert AJ, Speight PM, Bown SG. Photodynamic therapy of oral cancerphotosensitization with systemic aminolevulinic acid. Lancet. 1993;342: 147-148.
195. Szeimies RM, Sassy T, Landthaler M. Penetration potency of topical applied 5-aminolevulinic acid for photodynamic therapy of basal cell carcinoma. Photochem Photobiol. 1994;59:73-76.
196. Peng Q, Warloe T, Moan J, Steen H, Giercksky K-E, Nesland JM. Localization of ALA-induced porphyrins in normal and malignant tissues of mice, dogs and patients. Conference on photosensitization and photochemotherapy of cancer. 16-17 March 1993, Oslo. Abstract book; 1993:S4.
197. Peng Q, Warloe T, Moan J, et al. Distribution of 5-amino-levulinic acid-induced porphyrins in nodulo-ulcerative basal cell carcinoma. 1995;62:906-913.
198. Krosl G, Korbelik M, Dougherty GJ. Induction of immune cell infiltration into murine SCCVII tumor by Photofrin-based photodynamic therapy. Br J Cancer. 1995;71:549-555.
199. Kvam E, Stokke T, Moan J. The lengths of DNA fragments light-induced in the presence of a photosensitizer localized at the nuclear membrane of human cells. Biochim Biophys Acta. 1990;1049:33-37.
200. Peng Q, Moan J, Ma LW, Nesland JM. Uptake, localization and photodynamic effect of meso-tetra(hydroxyphenyl)porphyrin and its corresponding chlorin in normal and tumor tissues of mice bearing mammary carcinoma. Cancer Res. 1995;55:2620-2626.